Nutrition in inflammatory bowel disease

Best Practice and Research: Clinical Gastroenterology

Volumn 20, Issue 3, 2006, Pages 561-573

  O'Sullivan, Maria ^a   O'Morain, Colm ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Crohn's disease; enteral nutrition; osteoporosis; ulcerative colitis; undernutrition; vitamin D

Indexed keywords

CALCIUM; CORTICOSTEROID; GLUTAMINE; OMEGA 3 FATTY ACID; PLACEBO; SHORT CHAIN FATTY ACID; VITAMIN D;

ARTICLE; BODY FAT; CARBOHYDRATE DIET; CHILD CARE; CHILD DEVELOPMENT; CHILD GROWTH; CHILD NUTRITION; CROHN DISEASE; DIET RESTRICTION; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY FIBER; DIETARY INTAKE; DRUG EFFICACY; ENTERIC FEEDING; ENTERITIS; HEADACHE; HUMAN; INTESTINE SURGERY; LIPID DIET; MALNUTRITION; MUSCLE FUNCTION; NAUSEA; NOSE FEEDING; NUTRITIONAL DEFICIENCY; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; OSTEOPOROSIS; PATHOPHYSIOLOGY; PATIENT SELECTION; PRACTICE GUIDELINE; RECURRENT DISEASE; RISK FACTOR; RISK REDUCTION; THEORY; ULCERATIVE COLITIS; VITAMIN D DEFICIENCY; WEIGHT REDUCTION;

ADULT; BODY COMPOSITION; CHILD; CHILD DEVELOPMENT; CHILD NUTRITION PHYSIOLOGY; DIET; HUMANS; INFLAMMATORY BOWEL DISEASES; MALNUTRITION; NUTRITIONAL SUPPORT; OSTEOPOROSIS;

EID: 33745131773     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2006.03.001     Document Type: Article

References (68)

1. Mahmud N., and Weir D.G. The urban diet and Crohn's disease: is there a relationship ?. Eur J Gastroenterol Hepatol 13 2 (2001) 93-95
2. Shoda R., Matsueda K., Yamato S., and Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr 63 5 (1996) 741-745
3. Russel M., Engels L., Muris J., et al. Modern life in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol 10 3 (1998) 235-237
4. Persson P., Ahlbom A., and Hellers G. Diet and inflammatory bowel disease: a case-control study. Epidemiology 3 1 (1992) 47-52
5. Sonnenberg A. Geographic and temporal variations of sugar and margarine consumption in relation to Crohn's disease. Digestion 41 3 (1988) 161-171
6. Mishkin B., and Mishkin S. Dietary fads and gut mysteries versus nutrition with a grain of common sense. Can J Gastroenterol 11 4 (1997) 371-375
7. Gent A., Hellier M., Grace R., et al. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 343 (1994) 1359-1360
8. Pirlich M., Schutz T., Kemps M., et al. Prevalence of malnutrition in hospitalized medical patients: impact of underlying disease. Dig Dis 21 3 (2003) 245-251
9. Winter T.A., Lemmer E.R., O' Keefe S., and Ogden J.M. The effect of severe undernutrition, and subsequent refeeding on digestive function in human patients. Eur J Gastroenterol Hepatol 12 2 (2000) 191-196
10. Geerling B.J., Badart-Smook A., Stockbrugger R.W., and Brummer R.J. Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr 67 5 (1998) 919-926
11. Valentini L., Buening C., Pirlich M., et al. Impaired functional status despite apparently normal nutritional status in patients with quiescent Crohn's disease (CD). Gastroenterology 128 4 (2005) A-551
12. Jahnsen J., Falch J.A., Mowinckel P., and Aadland E. Body composition in patients with inflammatory bowel disease: a population-based study. Am J Gastroenterol 98 7 (2003) 1556-1562
13. Carter M.J., Lobo A.J., and Travis S.P.L. Guidelines for the management of inflammatory bowel disease in adults. Gut 53 supplement 5 (2004) v1-v16
14. Nic Suibhne T., O'Morain C., and O'Sullivan M. Protein undernutrition in Crohn's disease: an unrecognised problem?. Gastroenterology 128 4 (2005) A-312
15. Al-Jaouni R., Schneider S., Filippi J., et al. High prevalence of sarcopenia in patients with Crohn's disease: association with osteopenia. Gastroenterology 128 4 (2005) A-150
16. Valonqueiro A., Guerreiro C., Costa A., et al. Nutritional status and body composition in patients with Crohn's disease: a case-control study. Clin Nutr 24 4 (2005) 545
17. Schaffler A., Scholmerich J., and Buchler C. Mechanisms of disease: adipocytokines and visceral adipose tissue-emerging role in intestinal and mesenteric diseases. Nat Clin Pract Gastroenterol Hepatol 2 (2005) 103-111
18. Yamamoto K., Kiyohara T., Murayama Y., et al. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease. Gut 54 (2005) 789-796
19. Auvin S., Molinie C., Gower-Rousseau C., et al. Incidence, clinical presentation and localisation of pediatric inflammatory bowel disease at diagnosis in northern France (1998-99). Gut Suppl II 35 (2003) A53
20. Sawczenko A., and Sandhu B.K. Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child 88 (2003) 995-1000
21. Ballinger A.B., Azooz O., El-Haj T., et al. Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut 46 5 (2000) 694-700
22. Tomer G., Ceballos C., Concepcion E., and Benkov K.J. NOD2/CARD15 variants are associated with lower weight at diagnosis in children with Crohn's disease. Am J Gastroenterol 98 11 (2003) 2479-2484
23. Borrelli O., Bascietto C., Viola F., et al. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Dig Liver Dis 36 5 (2004) 342-347
24. Steiner S., Pfefferkorn M., Fitzgerald J., and Denne S. Infliximab improves protein and energy metabolism in pediatric Crohn's disease. Gastroenterology 128 4 (2005) A-106
25. Walters T., Gilman A., and Griffiths A. Infliximab therapy restores normal growth in children with chronically active severe crohn disease refractory to immunomodulatory therapy. Gastroenterology 128 4 (2005) A-27
26. Bernstein C.N., Blanchard J.F., Metge C., and Yogendran M. The association between corticosteroid use and development of fractures among IBD patients in a population-based database. Am J Gastroenterol 98 8 (2003) 1797-1801
27. Connell W., Maguire E., Ng K., et al. Teenage onset of crohn's disease is associated with an increased risk of osteoporosis in adulthood. Gastroenterology 128 4 (2005) A-317
28. Habtezion A., Silverberg M., Parkes R., et al. Risk factors for low bone density in Crohn's disease. Inflamm Bowel Dis 8 2 (2002) 87-92
29. Dresner-Pollak R., Gelb N., Rachmilewitz D., et al. Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones. Gastroenterology 127 (2005) 792-801
30. Fraser G., Ben-Bassat O., Fraser A., et al. Infliximab improves bine mineral density in patients with Crohn's disease. Gastroenterology 128 4 (2005) A-578
31. Ryan B.M., Russel M.G.V.M., Schurgers L., et al. Effect of antitumour necrosis factor a therapy on bone turnover in patients with active Crohn's disease: a prospective study. Aliment Pharmacol Ther 20 8 (2004) 851-857
32. Siffledeen J., Siminoski K., Steinhart H., et al. The frequency of vitamin D deficiency in adults with Crohn's disease. Can J Gastroenterol 17 8 (2003) 473-478
33. Tajika M., Matsuura A., Nakamura T., et al. Risk factors for vitamin D deficiency in patients with Crohn's disease. J Gastroenterol 39 6 (2004) 527-533
34. Pappa H., Gordon C., Cook T., et al. Prevalence of vitamin D deficiency is similarly high in young patients with Crohn's disease and ulcerative colitis. Gastroenterology 128 4 (2005) A-167
35. McCarthy D., Duggan P., O'Brien M., et al. Seasonality of vitamin D status and bone turnover in patients with Crohn's disease. Aliment Pharmacol Ther 21 9 (2005) 1073-1083
36. Siffledeen J.S., Fedorak R.N., Siminoski K., et al. Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone mineral density in Crohn's disease. Clin Gastroenterol Hepatol 3 (2005) 122-132
37. Sentongo T.A., Semaeo E.J., Stettler N., et al. Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr 76 5 (2002) 1077-1081
38. Duggan P., O'Brien M., Kiely M., et al. Vitamin K status in patients with Crohn's disease and relationship to bone turnover. Am J Gastroenterol 99 (2004) 2178-2185
39. Scott E.M., Gaywood I., and Scott B.B. Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British society of gastroenterology. Gut 46 supplement 1 (2000) i1-i8
40. Bernstein C.N., Leslie W.D., and Leboff M.S. American gastroenterological association medical position statement: guidelines on osteoporosis in gastrointestinal diseases. Gastroenterology 124 3 (2003) 791-794
41. van Staa T.P., Cooper C., Brusse L.S., et al. Inflammatory bowel disease and the risk of fracture. Gastroenterology 125 6 (2003) 1591-1597
42. Singleton K.D., Beckey V.E., and Wischmeyer P.E. Glutamine prevents activation of NF-kappaB and stress kinase pathways, attenuates inflammatory cytokine release, and prevents acute respiratory distress syndrome (ARDS)) following sepsis. Shock 24 (2005) 583-589
43. Ockenga J., Borchert K., Stuber E., et al. Glutamine-enriched total parenteral nutrition in patients with inflammatory bowel disease. Eur J Clin Nutr 59 (2005) 1302-1309
44. O'Morain C., and McGuinness A. Crohn's disease: enteral feeding. Current therapy in gastroenterology nad liver disease. 4th edn (1994), Mosby, St Lousi p. 278-81
45. Fernandez-Banares F., Cabre E., Esteve-Comas M., and Gassull M.A. How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials. JPEN J Parenter Enteral Nutr 19 5 (1995) 356-364
46. Messori A., Trallori G., G D.A., et al. Defined-formula diets versus steroids in the treatment of active Crohn's disease: a meta-analysis. Scand J Gastroenterol 31 3 (1996) 267-272
47. Zachos M., Zachos M., Tondeur M., and Griffiths A. Enteral nutritional therapy for inducing remission of Crohn's disease. Cochrane Database Syst Rev 3 (2001) CD000542
48. Gassull M.A. Review article: the role of nutrition in the treatment of inflammatory bowel disease. Aliment Pharmacol Ther 20 supplement 4 (2004) 79-83
49. O'Sullivan M., and O'Morain C. Nutritional therapy in inflammatory bowel disease. Curr Treat Options Gastroenterol 7 3 (2004) 191-198
50. Matsui T., Sakurai T., and Yao T. Nutritional therapy for Crohn's disease in Japan. J Gastroenterol 40 supplement 16 (2005) 25-31
51. Wilschanski M., Sherman P., Pencharz P., et al. Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. Gut 38 4 (1996) 543-548
52. Newby E., Sawczenko A., Thomas A., and Wilson D. Interventions for growth failure in childhood Crohn's disease. Cochrane Database Syst Rev 3 (2005)
53. Otley A., Murray A., Christensen B., et al. Primary enteral nutrition therapy induces and maintains remission, and reduces steroid exposure in a pediatric Crohn's disease population. Gastroenterology 128 4 (2005) A-584
54. Knight C., El-Matary W., Spray C., and Sandhu B. Long-term outcome of nutritional therapy in paediatric Crohn's disease. Clin Nutr 24 (2005) 775-779
55. Verma S., Brown S., Kirkwood B., and Giaffer M. Polymeric versus elemental diet as primary treatment in active Crohn's disease: a randomized, double-blind trial. Am J Gastroenterol 95 (2000) 735-739
56. Fell J.M., Paintin M., Arnaud-Battandier F., et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharm Ther 14 3 (2000) 281-289
57. Gassull M.A., Fernandez-Banares F., Cabre E., et al. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. Gut 51 2 (2002) 164-168
58. Hashimoto M., Okutsu T., Takeda T., et al. Beneficial therapeutic effect of elemental diet (Elental) in patients with Crohn's disease: comparison with prednihsolone in mouse models of colitis. Gastroenterology 128 4 supplement 2 (2005) A-553
59. Belluzzi A., Brignola C., Campieri M., et al. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 334 24 (1996) 1557-1560
60. Shimizu T., Fujii T., Suzuki R., et al. Effects of highly purified eicosapentaenoic acid on erythrocyte fatty acid composition and leukocyte and colonic mucosa leukotriene B4 production in children with ulcerative colitis. J Pediatr Gastroenterol Nutr 37 5 (2003) 581-585
61. Segain J.P., de La Bletiere D.R., Bourreille A., et al. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut 47 3 (2000) 397-403
62. Lomer M., Harvey R., Evans S., et al. Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. Eur J Gastroenterol Hepatol 13 2 (2001) 101-106
63. Lomer M., Grainger S., Ede R., et al. Lack of efficacy of a reduced microparticle diet in a multi-centred trial of patients with active Crohn's disease. Eur J Gastroenterol Hepatol 17 (2005) 377-384
64. Jowett S.L., Seal C.J., Phillips E., et al. Dietary beliefs of people with ulcerative colitis and their effect on relapse and nutrient intake. Clin Nutr 23 2 (2004) 161-170
65. Guerreiro C., Valonqueiro A., Costa M., et al. Dietary changes in patients with Crohn's Disease (CD): impact in macro and micronutient intake. Clin Nutr 24 4 (2005) 636
66. Reimund J.-M., Arondel Y., Escalin G., et al. Immune activation and nutritional status in adult Crohn's disease patients. Dig Liver Dis 37 6 (2005) 424-431
67. Yan Zhu Brett D.M., Monica F., and Margherita T. Calcium and 1,25-dihydroxyvitamin D3 target the TNF-a pathway to suppress experimental inflammatory bowel disease. Eur J Immunol 35 1 (2005) 217-224
68. Lochs H. Nutritional support in inflammatory bowel disease. In: Sobotka L. (Ed). Basics in Clinical Nutrition. 3rd edn (2004), Galen, Prague 314-321